{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:45:50Z","timestamp":1783439150727,"version":"3.54.6"},"reference-count":38,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000102","type":"journal-article","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:20:09Z","timestamp":1069366809000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Interventions for reducing the risk of mother-to-child transmission of HIV infection"],"prefix":"10.1002","volume":"2011","author":[{"given":"Peter","family":"Brocklehurst","sequence":"first","affiliation":[{"name":"University of Oxford; National Perinatal Epidemiology Unit; Old Road Campus Old Road Headington Oxford UK OX3 7LF"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,21]]},"reference":[{"key":"10.1002\/14651858.CD000102-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00006454-199506000-00012","article-title":"Zidovudine for the reduction of perinatal human immunodeficiency virus transmission: Pediatric AIDS Clinical Trials Group Protocol 076 - results and treatment recommendations","volume":"14","author":"Connor","year":"1995","journal-title":"Pediatri Infect Dis J"},{"key":"10.1002\/14651858.CD000102-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000102-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJM199611283352201","article-title":"Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant","volume":"335","author":"Sperling","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000102-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(98)11046-2","article-title":"6-month efficacy, tolerance and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial","volume":"353","author":"Dabis","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000102-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/00002030-199810000-00026","article-title":"Prevention of mother-to-child transmission of HIV in Africa: uptake of pregnant women in a clinical trial in Abidjan, Cote d'Ivoire","volume":"12","author":"Msellati","year":"1998","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD000102-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(99)80008-7","article-title":"Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial","volume":"354","author":"Guay","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000102-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1471-0528.1998.tb10087.x","article-title":"A randomised trial of mode of delivery in women infected with the human immunodeficiency virus","volume":"105","author":"Newell","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1002\/14651858.CD000102-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(98)08084-2","article-title":"Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial","volume":"353","author":"The European Mode of delivery Collaboration","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000102-BIB0009|cit9","unstructured":"Saba J The results of the PETRA intervention trial to prevent perinatal transmission in SubSaharan Africa. 6th Conference on Retroviruses and Opportunistic Infections; 1999; Chicago. www.retroconference.org\/99\/lect_symposia\/sym_session8.htm"},{"key":"10.1002\/14651858.CD000102-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(98)10411-7","article-title":"Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial","volume":"353","author":"Shaffer","year":"1999","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD000102-BIB0011|cit11","first-page":"151","article-title":"Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission - Thailand 1996-1998","volume":"47","author":"Vuthipongse","year":"1998","journal-title":"MMWR"},{"key":"10.1002\/14651858.CD000102-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/infdis\/175.2.283","article-title":"Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study Group","volume":"175","author":"Lambert","year":"1997","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1002\/14651858.CD000102-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1086\/314637","article-title":"Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of pediatric AIDS clinical trials group protocol 185","volume":"179","author":"Stiehm","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1002\/14651858.CD000102-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(98)10412-9","article-title":"Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomised trial","volume":"353","author":"Wiktor","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000102-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0140-6736(96)91486-5","article-title":"Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission","volume":"247","author":"Biggar","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000102-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00042560-199705010-00015","article-title":"Effects of vitamin A supplementation on viral load in HIV-1 infected pregnant women","volume":"15","author":"Coutsoudis","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1002\/14651858.CD000102-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0140-6736(98)04197-X","article-title":"Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1 infected women in Tanzania","volume":"351","author":"Fawzi","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000102-BIB0018|cit18","unstructured":"Lallemant M The North Thailand perinatal HIV prevention trial (NT-PHPT) study update"},{"key":"10.1002\/14651858.CD000102-BIB0019|cit19","unstructured":"Blanche S Rouzioux C Mandelbrot L Delfraissy J Mayaux M Zidovudine-lamivudine for prevention of mother to child HIV-1 transmission. Sixth Conference on Retroviruses and Opportunistic Infections; 1999; Chicago. Abstract 267"},{"key":"10.1002\/14651858.CD000102-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(99)07219-0","article-title":"Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues","volume":"354","author":"Blanche","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000102-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(94)90006-X","article-title":"Concorde: MRC\/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection","volume":"343","author":"Concorde Co-ordinating Committee","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000102-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000102-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.281.2.151","article-title":"Lack of long-term effects of in utero exposure to zidovudine among uninfected childen born to HIV-infected women","volume":"281","author":"Culnane","year":"1991","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000102-BIB0024|cit24","first-page":"S67","article-title":"Methodology of intervention trials to reduce mother-to-child transmission of HIV with special reference to developing countries","volume":"9 Suppl A","author":"Dabis","year":"1995","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD000102-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0140-6736(92)92115-V","article-title":"Risk of human immunodeficiency virus type 1 transmission through breast-feeding","volume":"240","author":"Dunn","year":"1992","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000102-BIB0026|cit26","first-page":"1064","article-title":"Mode of delivery and vertical transmission of HIV-1: a review of prospective studies","volume":"7","author":"Dunn","year":"1994","journal-title":"J Acquir Immune Def Syndr"},{"key":"10.1002\/14651858.CD000102-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM198707233170401","article-title":"The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex","volume":"317","author":"Fischl","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000102-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","article-title":"A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less","volume":"337","author":"Hammer","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000102-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199904013401301","article-title":"The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1","volume":"340","author":"The International Perinatal HIV Group","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000102-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM199606203342501","article-title":"Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child","volume":"334","author":"Landesman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000102-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(99)80009-9","article-title":"Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa","volume":"354","author":"Marseille","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000102-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1086\/515641","article-title":"Pharmacokinetics of nevirapine in human immunodeficiency virus type-1 infected pregnant women and their neonates","volume":"178","author":"Mirochnick","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1002\/14651858.CD000102-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00002030-199903110-00006","article-title":"A phase I\/II study of the safety and pharmacokinetics of nevirapine in HIV-1 infected pregnant Ugandan woman and their neonates (HIVNET 006)","volume":"13","author":"Musoke","year":"1888","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD000102-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(94)93056-2","article-title":"Maternal vitamin A deficiency and mother-to-child transmission of HIV-1","volume":"343","author":"Semba","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000102-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM199203263261303","article-title":"A survey of zidovudine use in pregnant women with human immunodeficiency virus infection","volume":"326","author":"Sperling","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000102-BIB0036|cit36","unstructured":"UNAIDS AIDS epidemic update: December 1998. Geneva: Joint United Nations Programme on HIV\/AIDS, 1998"},{"key":"10.1002\/14651858.CD000102-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM199811123392001","article-title":"Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus","volume":"339","author":"Wade","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000102-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00042560-199504120-00011","article-title":"Rates of mother-to-child transmission of HIV-1 in Africa, America and Europe: results of 13 perinatal studies","volume":"8","author":"The Working Group on MTCT of HIV","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retroviral"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD000102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:48:03Z","timestamp":1781005683000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000102"}},"subtitle":[],"editor":[{"name":"Cochrane HIV\/AIDS Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2002,1,21]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000102","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1,21]]}}}